Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 10/20 | 0.40 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13884310 | 0.85 | FOLH1 (0.40) | CPB2FOLH1MEN1GAAKMT2A | |
| SCHEMBL19483312 | 0.84 | KISS1R (0.39) | CPB2KISS1R | |
| SCHEMBL26743872 | 0.84 | KISS1R (0.39) | CPB2KISS1R | |
| SCHEMBL19483326 | 0.84 | KISS1R (0.39) | CPB2KISS1R | |
| SCHEMBL19401625 | 0.82 | CPB2 (0.43) | CPB2FOLH1KISS1RSMN1; SMN2KDM4A | |
| SCHEMBL13057114 | 0.82 | CPB2 (0.43) | CPB2FOLH1KISS1RSMN1; SMN2KDM4A | |
| SCHEMBL434550 | 0.82 | CPB2 (0.43) | CPB2FOLH1KISS1RSMN1; SMN2KDM4A | |
| SCHEMBL13167779 | 0.82 | FOLH1 (0.59) | FOLH1MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL19381704 | 0.82 | FOLH1 (0.59) | FOLH1MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL14445784 | 0.82 | FOLH1 (0.38) | CPB2FOLH1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357347-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | CPB2 3180/4885FOLH1 1910/4885KISS1R 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.